Mengru Zeng

650 total citations
21 papers, 350 citations indexed

About

Mengru Zeng is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mengru Zeng has authored 21 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 5 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mengru Zeng's work include Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Nutritional Studies and Diet (3 papers). Mengru Zeng is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Nutritional Studies and Diet (3 papers). Mengru Zeng collaborates with scholars based in China and United States. Mengru Zeng's co-authors include Fuyou Liu, Li Xiao, Jialu Liu, Zheng Dong, Lin Sun, Wenxia Yang, Shumin Zhang, Zhengwei Ma, Yan Yu and Jiefu Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Frontiers in Immunology.

In The Last Decade

Mengru Zeng

19 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengru Zeng China 11 124 121 54 52 50 21 350
Sujuan Xu China 13 180 1.5× 110 0.9× 34 0.6× 54 1.0× 52 1.0× 29 406
Chihiro Horimai Japan 7 155 1.3× 51 0.4× 56 1.0× 41 0.8× 47 0.9× 9 378
Hai-Ying Qi China 6 168 1.4× 157 1.3× 48 0.9× 54 1.0× 38 0.8× 12 403
Min W. Spencer United States 7 96 0.8× 130 1.1× 53 1.0× 66 1.3× 15 0.3× 8 388
Eiichiro Satake Japan 10 159 1.3× 82 0.7× 45 0.8× 24 0.5× 101 2.0× 25 348
Linda Lewis United States 7 124 1.0× 101 0.8× 43 0.8× 84 1.6× 31 0.6× 8 415
Shuiming Guo China 12 86 0.7× 61 0.5× 33 0.6× 26 0.5× 26 0.5× 19 384
Su Kil Park South Korea 13 97 0.8× 149 1.2× 30 0.6× 85 1.6× 18 0.4× 20 389
Jürgen Muser Switzerland 8 69 0.6× 93 0.8× 66 1.2× 26 0.5× 33 0.7× 11 402
Sam Hobson Sweden 7 75 0.6× 122 1.0× 44 0.8× 19 0.4× 18 0.4× 10 309

Countries citing papers authored by Mengru Zeng

Since Specialization
Citations

This map shows the geographic impact of Mengru Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengru Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengru Zeng more than expected).

Fields of papers citing papers by Mengru Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengru Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengru Zeng. The network helps show where Mengru Zeng may publish in the future.

Co-authorship network of co-authors of Mengru Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Mengru Zeng. A scholar is included among the top collaborators of Mengru Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengru Zeng. Mengru Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Xiaojun, Zhiwen Liu, Danyi Yang, et al.. (2024). A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney disease. Frontiers in Immunology. 15. 1365226–1365226. 1 indexed citations
3.
Chen, Guochun, Mengru Zeng, Zhiwen Liu, et al.. (2023). The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease. International Immunopharmacology. 122. 110589–110589. 1 indexed citations
4.
Wen, Jin, et al.. (2023). Exosomes in Diabetic Kidney Disease. SHILAP Revista de lepidopterología. 9(3). 131–142. 13 indexed citations
5.
Li, Xiaohui, Jialu Liu, Mengru Zeng, et al.. (2023). GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy. Frontiers in Immunology. 14. 1127612–1127612. 23 indexed citations
6.
Li, Xiaohui, Mengru Zeng, Jialu Liu, et al.. (2023). Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis. BMC Medical Genomics. 16(1). 63–63. 8 indexed citations
9.
Huang, Ying, Mengru Zeng, Lei Zhang, et al.. (2022). Dietary Inflammatory Potential Is Associated With Sarcopenia Among Chronic Kidney Disease Population. Frontiers in Nutrition. 9. 856726–856726. 29 indexed citations
10.
Huang, Ying, Lei Zhang, Mengru Zeng, et al.. (2022). Energy-Adjusted Dietary Inflammatory Index Is Associated With 5-Year All Cause and Cardiovascular Mortality Among Chronic Kidney Disease Patients. Frontiers in Nutrition. 9. 899004–899004. 15 indexed citations
11.
Yang, Wenxia, Yu Liu, Shumin Zhang, et al.. (2021). Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy. Acta Pharmacologica Sinica. 43(3). 659–671. 26 indexed citations
12.
Zeng, Mengru, Jin Wen, Zhengwei Ma, et al.. (2021). FOXO1-Mediated Downregulation of RAB27B Leads to Decreased Exosome Secretion in Diabetic Kidneys. Diabetes. 70(7). 1536–1548. 20 indexed citations
13.
Zeng, Mengru, Yu Liu, Fuyou Liu, et al.. (2020). Association between albumin-to-globulin ratio and long-term mortality in patients with chronic kidney disease: a cohort study. International Urology and Nephrology. 52(6). 1103–1115. 9 indexed citations
14.
Zeng, Mengru, Yu Liu, Fuyou Liu, et al.. (2020). J-shaped association of platelet-to-lymphocyte ratio with 5-year mortality among patients with chronic kidney disease in a prospective cohort study. International Urology and Nephrology. 52(10). 1943–1957. 9 indexed citations
15.
Yu, Yan, Zhengwei Ma, Jiefu Zhu, et al.. (2020). miR-214 represses mitofusin-2 to promote renal tubular apoptosis in ischemic acute kidney injury. American Journal of Physiology-Renal Physiology. 318(4). F878–F887. 45 indexed citations
16.
Zeng, Mengru, Jialu Liu, Wenxia Yang, et al.. (2019). Multiple‐microarray analysis for identification of hub genes involved in tubulointerstial injury in diabetic nephropathy. Journal of Cellular Physiology. 234(9). 16447–16462. 36 indexed citations
17.
Zeng, Mengru, Jialu Liu, Wenxia Yang, et al.. (2018). Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis. Journal of Cellular Biochemistry. 120(5). 8676–8688. 19 indexed citations
18.
Yang, Wenxia, Ying Luo, Shikun Yang, et al.. (2018). Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease. Clinical Science. 132(22). 2407–2422. 78 indexed citations
19.
Cao, Weijun, Xinyu Xu, Mengru Zeng, et al.. (2018). The Src homology and collagen A (ShcA) adaptor protein may participate in the pathogenesis of membranous lupus nephritis. Lupus. 27(13). 2014–2019. 2 indexed citations
20.
Zeng, Mengru, J Fan, Li J, et al.. (1999). [Intercellular adhesion molecule-1 expression in experimental liver fibrosis].. PubMed. 38(1). 37–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026